DC Circ. Rejects Trump's 'Far-Flung' Drug Pricing Rule
The D.C. Circuit on Tuesday rejected the Trump administration's effort to force pharmaceutical companies to disclose drug prices in television ads, saying the rule's "far-flung" attempt to lower prescription costs has...To view the full article, register now.
Already a subscriber? Click here to view full article